Bell IXL Investments Ltd v Life Therapeutics Ltd

Link copied
Case Copied 51 min read

FEDERAL COURT OF AUSTRALIA

Bell IXL Investments Ltd v Life Therapeutics Ltd [2008] FCA 1457

CORPORATIONS – directors’ duties – acting for a proper purpose – where plaintiff a shareholder in first defendant - where plaintiff requisitioned first defendant to convene an extraordinary general meeting of shareholders to consider a resolution to remove board of first defendant and replace it with three persons nominated by plaintiff – where first defendant subsequently issued new shares – whether new share issue was made for purpose of defeating plaintiff’s resolution and therefore improper – assessment of evidence and credit of directors of first defendant – Briginshaw principle – difference between inference and conjecture

WORDS AND PHRASES – “proper purpose” – “improper purpose”

Ashburton Oil NL v Alpha Minerals NL (1971) 123 CLR 614 cited
Briginshaw v Briginshaw (1938) 60 CLR 336 discussed
Harlowe’s Nominees Pty Ltd v Woodside (Lakes Entrance) Oil Company NL (1968) 121 CLR 483 referred to
Howard Smith Ltd v Ampol Petroleum Ltd [1974] 1 NSWLR 68 referred to
Idameneo (No 123) Pty Ltd v Symbion Health Ltd (2007) 64 ACSR 680 referred to
Jones v Dunkel (1959) 101 CLR 298 followed
Langton v Forsayth Mineral Exploration NL (1975) 1 ACLR 227 cited
Neat Holdings Pty Ltd v Karajan Holdings Pty Ltd (1992) 110 ALR 449 discussed
Ngurli Ltd v McCann (1953) 90 CLR 425 cited
Re Southern Resources Ltd (No 2) (1989) 15 ACLR 770 cited
Whitehouse v Carlton Hotel Pty Ltd (1987) 162 CLR 285 cited

BELL IXL INVESTMENTS LIMITED (ACN 113 669 908) v LIFE THERAPEUTICS LIMITED (ACN 001 001 145), AEGIS PARTNERS LIMITED and BELL POTTER NOMINEES LIMITED (ACN 088 899 601)

VID 432 OF 2008

MIDDLETON J
26 SEPTEMBER 2008
MELBOURNE


IN THE FEDERAL COURT OF AUSTRALIA

VICTORIA DISTRICT REGISTRY

VID 432 OF 2008

BETWEEN:

BELL IXL INVESTMENTS LIMITED (ACN 113 669 908)
Plaintiff

AND:

LIFE THERAPEUTICS LIMITED (ACN 001 001 145)
First Defendant

AEGIS PARTNERS LIMITED
Second Defendant

BELL POTTER NOMINEES LIMITED (ACN 088 899 601)
Third Defendant

JUDGE:

MIDDLETON J

DATE OF ORDER:

26 SEPTEMBER 2008

WHERE MADE:

MELBOURNE

THE COURT ORDERS THAT:

1.The parties confer and then file and serve by 4.00 pm on 3 October 2008:

(a)any submissions as to the appropriate orders to make and as to costs (including costs of and incidental to the trial before Finkelstein J);

(b)any submissions (and evidence) on the question of whether there should be an order:

(i)that a new general meeting be held with a new record date to be determined by the convenor of the meeting in accordance with reg 7.11.37 Corporations Regulation 2001 (Cth); or

(ii)alternatively, that the adjourned meeting be conducted upon notice with a new record date to be determined by the convenor of the meeting in accordance with reg 7.11.37 Corporations Regulation 2001 (Cth);  and

(c)any submissions on any further orders consequential upon dismissal of the proceeding (including any orders permitting the general meeting to proceed).

2.Any further hearing on the outstanding matters be adjourned to a date…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Bell IXL Investments Ltd v Life Therapeutics Ltd and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2008] FCA 1457
Decision Date

CaseChat Overview and Summary

In the case of Bell IXL Investments Ltd v Life Therapeutics Ltd, the primary issue before the court was whether an allotment of shares was issued for an improper purpose. This rehearing followed an earlier trial, which was reviewed by the Full Court. The plaintiff, Bell IXL Investments Ltd, argued that the allotment was improper and intended to consolidate the directors' positions, while the defendant, Life Therapeutics Ltd, contended that the allotment was made in the best interests of the company. The court was tasked with evaluating the evidence and determining whether the allotment of shares was made for a proper purpose.

The court considered the evidence presented by both parties, including the documentary material and the testimonies of the directors and other involved parties. The directors and Mr Waller of Aegis provided their testimonies, which the court found to be honest and credible. The court noted that the lack of written documentation did not undermine the credibility of the directors' evidence, as it was not their practice to document every discussion or decision. The court concluded that the allotment was made based on a commercial basis and was appropriate as a matter of business judgment.

After evaluating the evidence, the court found that the purpose of the allotment was not as described by the plaintiff. The court concluded that the allotment was made in the best interests of Life Therapeutics Ltd, and not for an improper purpose. Consequently, the court dismissed the proceeding and ordered the parties to confer and submit further submissions on the appropriate orders to make, including any consequential orders and the possibility of holding a new general meeting.

Orders

Orders of the court

1. The parties confer and then file and serve by 4.00 pm on 3 October 2008:

(a) any submissions as to the appropriate orders to make and as to costs (including costs of and incidental to the trial before Finkelstein J);

(b) any submissions (and evidence) on the question of whether there should be an order:

(i) that a new general meeting be held with a new record date to be determined by the convenor of the meeting in accordance with reg 7.11.37 Corporations Regulation 2001 (Cth); or

(ii) alternatively, that the adjourned meeting be conducted upon notice with a new record date to be determined by the convenor of the meeting in accordance with reg 7.11.37 Corporations Regulation 2001 (Cth); and

(c) any submissions on any further orders consequential upon dismissal of the proceeding (including any orders permitting the general meeting to proceed).

2. Any further hearing on the outstanding matters be adjourned to a date to be fixed.

Background

Background to the litigation

This proceeding concerns whether an allotment of shares was issued for an improper purpose and is a rehearing of a trial heard by another Judge of this Court as ordered by the Full Court on 15 August 2008. For the reasons which follow, after a consideration of the evidence before me on this rehearing, I have come to the view that the allotment was not for an improper purpose and was made bona fide in the best interests of Life Therapeutics Limited (‘LFE’). Contrary to the contention of the plaintiff, I do not accept that the allotment of shares was done to defeat any perceived predator or to consolidate the collective position of the directors of LFE.BACKGROUND LFE is a public company whose shares are listed on the Australian Securities Exchange (‘ASX’). Before the allotment of the shares in issue in this proceeding, LFE had issued 123,223,857 shares with voting rights. Between 14 May and 4 June 2008 Bell IXL Investments Limited (‘Bell IXL’) acquired 9,517,734 shares in LFE. Bell IXL’s shares in LFE together with those of its associate, K Pagnin Pty Limited (3,018,000 shares) (‘K Pagnin’), comprised approximately 10.17% of the issued capital of LFE. On 23 May 2008 Bell IXL requisitioned LFE to convene an extraordinary general meeting of shareholders to consider resolutions to remove the current board and replace it with three persons nominated by Bell IXL. On 12 June 2008 LFE convened that meeting for 23 July 2008. The meeting has been adjourned as a result of orders of this Court. On 9 June 2008 Aegis Partners Limited (‘Aegis’) agreed to accept a placement of 15% of LFE’s issued shares at 7 cents per share. Aegis informed LFE that clients of Aegis would take 18,483,578 shares at 7 cents per share. On 16 June 2008 LFE announced to the ASX that it had agreed to issue to Aegis 18,483,578 fully paid ordinary shares (representing 15% of its total issued capital) at 7 cents per share. At a board meeting of LFE on 17 June 2008, the directors noted that a subscription application for 18,483,578 shares (to raise $1,293,850.46) had been received from Aegis on 12 June 2008 and resolved to approve that issue and placement. Under the subscription agreement between LFE and Aegis, Aegis could nominate nominees to whom the shares were to be issued. On 4 July 2008 LFE received the subscription amount for the shares and announced to the ASX that the placement to Aegis had been completed. The shares were not allotted to Aegis but rather, in accordance with instructions from Aegis, were allotted to Bell Potter who allocated them to various nominee account holders. On 10 July 2008 LFE announced to the ASX that Aegis had directed Bell Potter to place the shares directly with various beneficial owners. This allotment represented approximately 13.04% of the voting shares in LFE and reduced Bell IXL’s interest in LFE’s capital to approximately 8.85% (at least as at 4 June 2008). Before the month of May 2008 the directors of LFE had considered a capital raising by the company for a sum between $5 million and $20 million. On a date which was contested between the parties, two of LFE’s directors, Messrs Bellman and Milne, met with Mr Booth of Asandas, a licensed stockbroker, to discuss a capital raising by LFE (‘the Booth meeting’). Neither Mr Booth nor Asandas was retained as a broker by LFE. The Booth meeting led to a chain of events which resulted in the allotment of the shares in issue on 4 July 2008.

Evidence

Evidence Before The Court

Ultimately, each case must turn on its facts, after an assessment of all the evidence, which includes the documentary material, but read in light of other admissible evidence which may impact upon the meaning to be given to documentary evidence and the context of such documentary evidence and the proper inferences that may be drawn. The evidence of directors must be considered and evaluated, always in the context of the other evidence before the court. In some circumstances a court may reject the evidence of directors, not because it is intentionally false, but because in the circumstances the overwhelming context is to the contrary, which leads the court to conclude that the evidence of the directors is more reconstruction than recollection. EVIDENCE OF THE DIRECTORS AND MR WALLER OF AEGIS Each director and Mr Waller gave evidence and was subjected to cross-examination and an attack upon their credit. I have come to the view that I should accept the evidence of each of the directors and Mr Waller of Aegis. They all answered the questions asked of them directly and without prevarication and, in my view, honestly. For the reasons given in the course of this judgment, I do not accept that the context of the allotment of shares is overwhelmingly against the evidence given as to the purpose of the allotment. There was a commercial basis for the allotment and, in my view, it was appropriate as a matter of business judgment for the directors in view of the history of LFE and potential future activities. One attack upon the credibility of the directors was based upon the lack of any proper board papers and lack of documents evidencing any real search for the placement of the shares. Bell IXL’s contention was that the lack of any proper board papers and the lack of documents evidencing any real search for a placement was the best evidence of the improprieties of the directors. However, as I have said, I am satisfied that it was not the practice of these directors to record in writing, whether by diary note or otherwise, the content of ongoing discussions amongst themselves or with third parties. The directors did not run LFE by recording or minuting each step of every transaction. Of course, it is not the function of the board minutes to confirm decisions, such as the decision taken on 19 May 2008 to meet with Mr Booth on 20 May 2008 to discuss the placement. The fact that the directors so acted is consistent with the circumstances of the directors assuming their defacto ‘executive’ roles at a critical time for LFE, where it had no staff in Australia, and where the directors were compelled to perform all the executive and non-executive functions in order to assist the management of the company. It would be one thing if every other negotiation or transaction and the like conducted by the board had been meticulously recorded. In such circumstances, the absence of documents in this one transaction might be the basis of an appropriate inference. I find that the directors conducted negotiations on the telephone and habitually conferred with each other either in person or on the telephone without making notes of their negotiations or discussions between themselves.

Decision

Reasons for decision

MIDDLETON J
I am not saying the email of 9 July may not be relevant to showing (on Bell IXL’s case) an overall strategy of improper purpose. However, in the end, the conclusion I have reached is that irrespective of the wording adopted in the 9 July email, the purpose in making the allotment was not that described by Bell IXL. I have reached this conclusion on the basis of all the evidence before me including the evidence of all the actual persons involved in the decision-making in May and June 2008.CONCLUSION In view of the above, I propose to dismiss the proceeding and make other orders upon hearing further from the parties.

Ratio Decidendi

Legal Principle Established

Established by: MIDDLETON J